Recombinant alpha-2A interferon
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant alpha-2A interferon, covering 2021-11-03 to 2021-11-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma [Phase 2]